Slow-cycling therapy-resistant cancer cells

Stem Cells and Development

Volumn 21, Issue 10, 2012, Pages 1822-1830

  Moore, Nathan ^a   Houghton, Jeanmarie ^a   Lyle, Stephen ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; FLUOROURACIL; OXALIPLATIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL CULTURE; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL ISOLATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENESCENCE; SLOW CYCLING TUMOR CELL; THERAPY RESISTANCE;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; FLUORESCEINS; FLUORESCENT DYES; FLUOROURACIL; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASMS, EXPERIMENTAL; ORGANOPLATINUM COMPOUNDS; SUCCINIMIDES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84862901505     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2011.0477     Document Type: Article

References (24)

1. Andre T, C Boni, M Navarro, J Tabernero, T Hickish, C Topham, A Bonetti, P Clingan, J Bridgewater, F Rivera and A de Gramont. (2009). Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 27:3109-3116.
2. Brewster AM, GN Hortobagyi, KR Broglio, SW Kau, CA Santa-Maria, B Arun, AU Buzdar, DJ Booser, V Valero, M Bondy and FJ Esteva. (2008). Residual risk of breast cancer recurrence 5 years after adjuvant therapy. J Natl Cancer Inst 100:1179-1183.
3. Bao S, Q Wu, RE McLendon, Y Hao, Q Shi, AB Hjelmeland, MW Dewhirst, DD Bigner and JN Rich. (2006). Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444:756-760.
4. Jung Y and SJ Lippard. (2007). Direct cellular responses to platinum-induced DNA damage. Chem Rev 107:1387-1407.
5. Papamichael D. (1999). The use of thymidylate synthase inhibitors in the treatment of advanced colorectal cancer: current status. Oncologist 4:478-487.
6. Selleri S, F Arnaboldi, M Palazzo, U Hussein, A Balsari and C Rumio. (2005). Caveolin-1 is expressed on multipotent cells of hair follicles and might be involved in their resistance to chemotherapy. Br J Dermatol 153:506-513.
7. Morshead CM, BA Reynolds, CG Craig, MW McBurney, WA Staines, D Morassutti, S Weiss and D van der Kooy. (1994). Neural stem cells in the adult mammalian forebrain: a relatively quiescent subpopulation of subependymal cells. Neuron 13:1071-1082.
8. Roesch A, M Fukunaga-Kalabis, EC Schmidt, SE Zabierowski, PA Brafford, A Vultur, D Basu, P Gimotty, T Vogt and M Herlyn. (2010). A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 141:583-594.
9. Kusumbe AP and SA Bapat. (2009). Cancer stem cells and aneuploid populations within developing tumors are the major determinants of tumor dormancy. Cancer Res 69:9245-9253.
10. Dembinski JL and S Krauss. (2009). Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma. Clin Exp Metastasis 26:611-623.
11. Fillmore CM and C Kuperwasser. (2008). Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res 10:R25.
12. Grimshaw MJ, L Cooper, K Papazisis, JA Coleman, HR Bohnenkamp, L Chiapero-Stanke, J Taylor-Papadimitriou and JM Burchell. (2008). Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells. Breast Cancer Res 10:R52.
13. Cheng T, N Rodrigues, H Shen, Y Yang, D Dombkowski, M Sykes and DT Scadden. (2000). Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 287:1804-1808.
14. Dekaney CM, AS Gulati, AP Garrison, MA Helmrath and SJ Henning. (2009). Regeneration of intestinal stem/progenitor cells following doxorubicin treatment of mice. Am J Physiol Gastrointest Liver Physiol 297:G461-G470.
15. Potten CS. (1998). Stem cells in gastrointestinal epithelium: numbers, characteristics and death. Philos Trans R Soc Lond B Biol Sci 353:821-830.
16. Welm BE, SB Tepera, T Venezia, TA Graubert, JM Rosen and MA Goodell. (2002). Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev Biol 245:42-56.
17. Shackleton M, F Vaillant, KJ Simpson, J Stingl, GK Smyth, ML Asselin-Labat, L Wu, GJ Lindeman and JE Visvader. (2006). Generation of a functional mammary gland from a single stem cell. Nature 439:84-88.
18. Pece S, D Tosoni, S Confalonieri, G Mazzarol, M Vecchi, S Ronzoni, L Bernard,GViale,PGPelicci and PP Di Fiore. (2010). Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell 140:62-73.
19. Chikamatsu K, H Ishii, G Takahashi, A Okamoto, M Moriyama, K Sakakura and K Masuyama. (2011). Resistance to apoptosis-inducing stimuli in CD44 + head and neck squamous cell carcinoma cells. Head Neck [Epub ahead of print]; DOI: 10.1002/hed.21732.
20. Harper LJ, DE Costea, L Gammon, B Fazil, A Biddle and IC Mackenzie. (2010). Normal and malignant epithelial cells with stem-like properties have an extended G2 cell cycle phase that is associated with apoptotic resistance. BMC Cancer 10:166.
21. Quintana E, M Shackleton, MS Sabel, DR Fullen, TM Johnson and SJ Morrison. (2008). Efficient tumour formation by single human melanoma cells. Nature 456:593-598.
22. Shmelkov SV, JM Butler, AT Hooper, A Hormigo, J Kushner, T Milde, R St Clair, M Baljevic, I White, et al. (2008). CD133 expression is not restricted to stem cells, and both CD133 + and CD133-metastatic colon cancer cells initiate tumors. J Clin Invest 118:2111-2120.
23. Ricci-Vitiani L, DG Lombardi, E Pilozzi, M Biffoni, M Todaro, C Peschle and R De Maria. (2007). Identification and expansion of human colon-cancer-initiating cells. Nature 445:111-115.
24. Gao MQ, YP Choi, S Kang, JH Youn and NH Cho. (2010). CD24 + cells from hierarchically organized ovarian cancer are enriched in cancer stem cells. Oncogene 29:2672-2680.